Soleus Capital

Soleus Capital Management, L.P. is a distinguished private investment firm headquartered in Greenwich, Connecticut, established in 2009. The firm has carved out a specialized niche within the healthcare sector, demonstrating a keen focus on biotechnology, pharmaceuticals, medical devices, and diagnostics. Operating as a "crossover fund," Soleus Capital strategically deploys capital into both public and private companies, leveraging a deep, fundamental, and research-driven approach to identify and support promising innovators within the life sciences ecosystem. Their investment philosophy emphasizes long-term value creation through rigorous due diligence and a comprehensive understanding of market dynamics and scientific advancements.

A testament to their robust investment strategy and market confidence, Soleus Capital successfully closed its second fund, Soleus Capital Fund II, L.P., at an impressive $1.1 billion in 2018. This significant capital base underscores their capacity for substantial investments. The firm's Assets Under Management (AUM) have consistently remained around the $1.1 billion mark in recent years, reflecting their stable and impactful presence in the healthcare investment landscape. This substantial pool of capital enables them to engage in meaningful partnerships and provide significant financial backing to their portfolio companies.

Soleus Capital typically targets growth-stage private companies and pre-IPO opportunities, often participating in large, syndicated funding rounds. Their investment activity frequently involves contributing to rounds that exceed $100 million, such as their participation in the $100 million Series B for ReCode Therapeutics in 2021, or the $150 million Series B for Third Harmonic Bio in the same year. While specific individual check sizes can vary based on the round structure and the firm's stake, their involvement in such substantial financings indicates a typical first cheque size ranging from tens of millions of dollars, reflecting their commitment to providing significant growth capital.

The firm's expertise in healthcare, combined with its flexible investment mandate across public and private markets, positions Soleus Capital as a key financial partner for companies navigating complex development and commercialization pathways. Their strategic investments aim to accelerate the growth and market penetration of innovative healthcare solutions, contributing to advancements across the sector.